Additive effects of epinephrine and corticotropin-releasing factor (CRF) on adrenocorticotropin release in rat anterior pituitary cells
- PMID: 6301454
- DOI: 10.1016/0006-291x(83)91171-3
Additive effects of epinephrine and corticotropin-releasing factor (CRF) on adrenocorticotropin release in rat anterior pituitary cells
Abstract
The ability of epinephrine to potentiate the action of corticotropin-releasing factor (CRF) was studied in rat anterior pituitary cells in primary culture. Increasing concentrations of epinephrine cause a maximal 6.5-fold stimulation of ACTH release while a 10-fold increase is induced by 5 nM CRF. The two substances exert an additive effect on ACTH release. Although epinephrine alone has no effect on cyclic AMP levels, it causes a maximal 4-fold increase in CRF-induced cyclic AMP accumulation. The stimulatory effect of epinephrine on both parameters is inhibited by the highly specific alpha 1-adrenergic antagonist prazosin but not by the beta-adrenergic antagonist (-)propranolol. Dexamethasone causes a 75% inhibition of ACTH release induced by the combined action of CRF and epinephrine. The present data show that the additive effect of epinephrine on CRF-induced ACTH release is achieved through an alpha-adrenergic receptor and is accompanied by a marked stimulation of intracellular cyclic AMP levels.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
